Heather L. Douglas

BMO Capital Markets Corp. (Broker) is the broker/dealer division of BMO Capital Markets Corp., a full-service North American financial services provider headquartered in New York City. The firm was founded in 1998 and is a subsidiary of BMO Financial Corp., which is owned by Bank of Montreal (NYSE, TSX: BMO) in Canada. BMO Capital Markets offers corporate, institutional and government clients access to a variety of products and services including equity and debt underwriting, corporate lending and project financing, merger and acquisitions advisory services, merchant banking, securitization, treasury and market risk management, debt and equity research and institutional sales and trading.

BMO Capital Markets Corp. (Canada) (BMO Capital Markets-Canada) is the Canadian brokerage arm of BMO Capital Markets Corp., a full-service financial services provider in the US. The firm was founded in 1817 and is a subsidiary of BMO Asset Management, Inc., which is owned by Bank of Montreal (NYSE, TSX: BMO) in Canada. Headquartered in Toronto, BMO Capital Markets-Canada provides full-service, institutional brokerage services to corporate, institutional and government clients around the world.

Founded in 2002, Thomas Weisel Partners Canada, Inc., formerly Westwind Partners, Inc., is an institutional investment bank, investment advisor and broker/dealer headquartered in Toronto, Ontario. The firm is a subsidiary of Thomas Weisel Partners Group, Inc. (Nasdaq: TWPG), a San Francisco-based investment banking firm. Their ultimate parent is Stifel Financial Corp. (NYSE: SF). Thomas Weisel Partners Canada specializes in the growth sectors of the economy with a particular focus on the consumer, energy, healthcare, Internet, media, telecommunications, metals/mining and technology sectors. They provide equity research on US, Canadian and UK-listed companies, equity trading capabilities and advice to corporations on M&A, financing and restructuring transactions. Thomas Weisel Partners Canada is a member of the CIPF/FCPE and the IIROC.

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Stifel Nicolaus Canada, Inc. is a broker/dealer headquartered in Toronto, Ontario. The firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a full-service regional brokerage and investment banking firm that was founded in 1890. Stifel Nicolaus offers institutional investors differentiated, research-driven equity products with a focus on value and service. In addition to the company's comprehensive institutional coverage, the firm also maintains one of the largest retail distribution networks in the U.S. Stifel Nicolaus' Fixed Income Group offers the company’s institutional clients a comprehensive combination of products and services. The company expertise in trading, research and investment banking enables us to partner with the company clients to develop solutions designed to meet their needs. Stifel Nicolaus' research focuses on all market-caps, but the firm has particular expertise in small- and mid-cap research. The company research efforts focus on 45 specialties in 12 sectors including: aerospace, business services, consumer/retail, diversified industrials, education, energy/power, financial institutions, healthcare, Internet, metals/mining, real estate, technology and transportation.